About
Oncology drugs
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibody
Team (2)
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
15
As Collaborator
2
Total Enrollment
823
By Phase
PHASE1: 11NA: 1PHASE1/PHASE2: 3PHASE2: 2
By Status
TERMINATED: 8COMPLETED: 4RECRUITING: 3ENROLLING_BY_INVITATION: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT06930755Lead Sponsor
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
PHASE1Recruiting
24 participants
Started: Oct 30, 2025 · Completed: Sep 26, 2027
NCT06931626Lead Sponsor
Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
PHASE1Recruiting
10 participants
Started: Aug 15, 2025 · Completed: Feb 28, 2027
NCT06549790Lead Sponsor
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
PHASE1Recruiting
124 participants
Started: Oct 16, 2024 · Completed: May 15, 2030
NCT06451458Collaborator
ECHO for Diabetes and Multiple Chronic Conditions Study
NAEnrolling by invitation
20 participants
Started: Oct 16, 2024 · Completed: Jun 30, 2028
NCT05027594Lead Sponsor
Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma
PHASE1Terminated
5 participants
Started: Sep 9, 2022 · Completed: Jan 8, 2024
Locations (1)
Headquarters
Nerviano, Italy
Map
Loading map...